<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"	
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	xmlns:media="http://search.yahoo.com/mrss/"
	>
<channel>
	<title>Cardiology: Non-Interventional &#187; The Doctor&#039;s Channel</title>
	<atom:link href="http://www.thedoctorschannel.com/channels/cardiology-noninterventional/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.thedoctorschannel.com</link>
	<description>Internet TV for Doctors</description>
	<lastBuildDate>Wed, 16 May 2012 23:34:19 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1.2</generator>
			<item>
		<title>Cardiac resynchronization reduces risk of recurring heart failure events</title>
		<link>http://www.thedoctorschannel.com/view/cardiac-resynchronization-reduces-risk-of-recurring-heart-failure-events/</link>
		<pubDate>Thu, 04 Aug 2011 20:07:00 +0000</pubDate> 
				<category><![CDATA[Cardiology]]></category>
		<category><![CDATA[Cardiology: Interventional]]></category>
		<category><![CDATA[Cardiology: Non-Interventional]]></category>
		<category><![CDATA[Hospitalist]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[cardiac resynchronization therapy]]></category>
		<category><![CDATA[CRT]]></category>
		<category><![CDATA[Dr. Ilan Goldenberg]]></category>
		<category><![CDATA[Heart Failure]]></category>
		<category><![CDATA[Journal of the American College of Cardiology]]></category>
		<guid isPermaLink="false">http://new.thedoctorschannel.com/view/cardiac-resynchronization-reduces-risk-of-recurring-heart-failure-events/</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – Cardiac resynchronization therapy not only reduces the risk of a first heart failure event but also recurring events, according to an analysis of data from the MADIT-CRT trial. “The results of the present MADIT-CRT sub-study show for the first time that CRT is associated with a pronounced reduction in the -]]></description>
		
			<media:content duration="1:45" medium="video">
		<media:title><![CDATA[Cardiac resynchronization reduces risk of recurring heart failure events]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – Cardiac resynchronization therapy not only reduces the risk of a first heart failure event but also recurring events, according to an analysis of data from the MADIT-CRT trial. “The results of the present MADIT-CRT sub-study show for the first time that CRT is associated with a pronounced reduction in the -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/cardiac-resynchronization-reduces-risk-of-recurring-heart-failure-events/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2011/12/4586.jpg"/>
	<media:keywords><![CDATA[cardiac resynchronization therapy,CRT,Dr. Ilan Goldenberg,Heart Failure,Journal of the American College of Cardiology]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Adverse thyroid effects of generic and brand-name amiodarone similar</title>
		<link>http://www.thedoctorschannel.com/view/adverse-thyroid-effects-of-generic-and-brand-name-amiodarone-similar/</link>
		<pubDate>Tue, 12 Jul 2011 18:57:00 +0000</pubDate> 
				<category><![CDATA[Cardiology]]></category>
		<category><![CDATA[Cardiology: Interventional]]></category>
		<category><![CDATA[Cardiology: Non-Interventional]]></category>
		<category><![CDATA[Family Medicine]]></category>
		<category><![CDATA[Hospitalist]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Nurses/NP/PA]]></category>
		<category><![CDATA[Pharmacists]]></category>
		<category><![CDATA[Public Health & Prevention]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[AF]]></category>
		<category><![CDATA[amiodarone]]></category>
		<category><![CDATA[atrial fibrillation]]></category>
		<category><![CDATA[Canadian Medical Association Journal]]></category>
		<category><![CDATA[Dr. Louise Pilote]]></category>
		<guid isPermaLink="false">http://new.thedoctorschannel.com/view/adverse-thyroid-effects-of-generic-and-brand-name-amiodarone-similar/</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – Among patients with atrial fibrillation on amiodarone, the incidence of thyroid dysfunction is identical in those taking the brand-name formulation of the drug and those taking a generic version, according to the results of a Canadian study. Dr. Louise Pilote, at McGill University Health Center in Montreal, Quebec, and colleagues -]]></description>
		
			<media:content duration="1:04" medium="video">
		<media:title><![CDATA[Adverse thyroid effects of generic and brand-name amiodarone similar]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – Among patients with atrial fibrillation on amiodarone, the incidence of thyroid dysfunction is identical in those taking the brand-name formulation of the drug and those taking a generic version, according to the results of a Canadian study. Dr. Louise Pilote, at McGill University Health Center in Montreal, Quebec, and colleagues -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/adverse-thyroid-effects-of-generic-and-brand-name-amiodarone-similar/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2011/12/4534.jpg"/>
	<media:keywords><![CDATA[AF,amiodarone,atrial fibrillation,Canadian Medical Association Journal,Dr. Louise Pilote]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Pulmonary disorders increased in AF patients taking amiodarone</title>
		<link>http://www.thedoctorschannel.com/view/pulmonary-disorders-increased-in-af-patients-taking-amiodarone/</link>
		<pubDate>Mon, 11 Jul 2011 18:13:00 +0000</pubDate> 
				<category><![CDATA[Cardiology]]></category>
		<category><![CDATA[Cardiology: Interventional]]></category>
		<category><![CDATA[Cardiology: Non-Interventional]]></category>
		<category><![CDATA[Critical Care]]></category>
		<category><![CDATA[Emergency Medicine]]></category>
		<category><![CDATA[Family Medicine]]></category>
		<category><![CDATA[Hospitalist]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Nurses/NP/PA]]></category>
		<category><![CDATA[Pulmonary Medicine]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[AF]]></category>
		<category><![CDATA[American Journal of Cardiology]]></category>
		<category><![CDATA[amiodarone]]></category>
		<category><![CDATA[atrial fibrillation]]></category>
		<category><![CDATA[Dr. Louise Pilote]]></category>
		<category><![CDATA[Pulmonary disorders]]></category>
		<guid isPermaLink="false">http://new.thedoctorschannel.com/view/pulmonary-disorders-increased-in-af-patients-taking-amiodarone/</guid>
		<description><![CDATA[NEW YORK (Reuters Health) &#8211; A new population-based study finds the incidence of pulmonary complications associated with amiodarone to be relatively low, but still 50% higher among patients with atrial fibrillation who take the antiarrhythmic drug than in those who do not. Those findings are reported in the American Journal of Cardiology online by Dr. -]]></description>
		
			<media:content duration="1:28" medium="video">
		<media:title><![CDATA[Pulmonary disorders increased in AF patients taking amiodarone]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) &#8211; A new population-based study finds the incidence of pulmonary complications associated with amiodarone to be relatively low, but still 50% higher among patients with atrial fibrillation who take the antiarrhythmic drug than in those who do not. Those findings are reported in the American Journal of Cardiology online by Dr. -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/pulmonary-disorders-increased-in-af-patients-taking-amiodarone/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2011/12/4532.jpg"/>
	<media:keywords><![CDATA[AF,American Journal of Cardiology,amiodarone,atrial fibrillation,Dr. Louise Pilote,Pulmonary disorders]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>&#8216;Real-world&#8217; data fail to support cancer link to angiotensin receptor blockers</title>
		<link>http://www.thedoctorschannel.com/view/real-world-data-fail-to-support-cancer-link-to-angiotensin-receptor-blockers-2/</link>
		<pubDate>Thu, 28 Apr 2011 20:57:00 +0000</pubDate> 
				<category><![CDATA[Cardiology]]></category>
		<category><![CDATA[Cardiology: Non-Interventional]]></category>
		<category><![CDATA[Family Medicine]]></category>
		<category><![CDATA[Hospitalist]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Nurses/NP/PA]]></category>
		<category><![CDATA[Pharmacists]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[angiotensin receptor blockers]]></category>
		<category><![CDATA[ARBs]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Dr. Bjorn Pasternak]]></category>
		<category><![CDATA[Lancet Oncology]]></category>
		<category><![CDATA[lung cancer]]></category>
		<guid isPermaLink="false">http://new.thedoctorschannel.com/view/real-world-data-fail-to-support-cancer-link-to-angiotensin-receptor-blockers-2/</guid>
		<description><![CDATA[NEW YORK (Reuters Health) &#8211; A Danish observational study provides no evidence that use of angiotensin receptor blockers (ARBs) is associated with an increased risk of incident cancer overall or of lung cancer. Concern about increased risks of cancer was raised by results of a meta-analysis of nine randomized trials that appeared in the Lancet -]]></description>
		
			<media:content duration="1:00" medium="video">
		<media:title><![CDATA[&#8216;Real-world&#8217; data fail to support cancer link to angiotensin receptor blockers]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) &#8211; A Danish observational study provides no evidence that use of angiotensin receptor blockers (ARBs) is associated with an increased risk of incident cancer overall or of lung cancer. Concern about increased risks of cancer was raised by results of a meta-analysis of nine randomized trials that appeared in the Lancet -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/real-world-data-fail-to-support-cancer-link-to-angiotensin-receptor-blockers-2/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2011/06/4298.jpg"/>
	<media:keywords><![CDATA[angiotensin receptor blockers,ARBs,cancer,Dr. Bjorn Pasternak,Lancet Oncology,lung cancer]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Atrial flutter responds well to electrocardioversion in the emergency department</title>
		<link>http://www.thedoctorschannel.com/view/atrial-flutter-responds-well-to-electrocardioversion-in-the-emergency-department-2/</link>
		<pubDate>Wed, 02 Feb 2011 00:36:00 +0000</pubDate> 
				<category><![CDATA[Cardiology]]></category>
		<category><![CDATA[Cardiology: Non-Interventional]]></category>
		<category><![CDATA[Emergency Medicine]]></category>
		<category><![CDATA[Hospitalist]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[Annals of Emergency Medicine]]></category>
		<category><![CDATA[antiarrhythmic drug treatment]]></category>
		<category><![CDATA[Atrial flutter]]></category>
		<category><![CDATA[Dr. Frank Scheuermeyer]]></category>
		<category><![CDATA[electrical cardioversion]]></category>
		<guid isPermaLink="false">http://new.thedoctorschannel.com/view/atrial-flutter-responds-well-to-electrocardioversion-in-the-emergency-department-2/</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – Atrial flutter seen in patients in the emergency department (ED) resolves more often with electrical cardioversion than with antiarrhythmic drug treatment, and long-term outcomes are good, a Canadian study indicates. “The ED management of patients with atrial flutter is controversial,” the researchers note in the Annals of Emergency Medicine online -]]></description>
		
			<media:content duration="1:50" medium="video">
		<media:title><![CDATA[Atrial flutter responds well to electrocardioversion in the emergency department]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – Atrial flutter seen in patients in the emergency department (ED) resolves more often with electrical cardioversion than with antiarrhythmic drug treatment, and long-term outcomes are good, a Canadian study indicates. “The ED management of patients with atrial flutter is controversial,” the researchers note in the Annals of Emergency Medicine online -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/atrial-flutter-responds-well-to-electrocardioversion-in-the-emergency-department-2/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2011/06/4052.jpg"/>
	<media:keywords><![CDATA[Annals of Emergency Medicine,antiarrhythmic drug treatment,Atrial flutter,Dr. Frank Scheuermeyer,electrical cardioversion]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Vernakalant bests amiodarone for recent-onset atrial fibrillation</title>
		<link>http://www.thedoctorschannel.com/view/vernakalant-bests-amiodarone-for-recent-onset-atrial-fibrillation-2/</link>
		<pubDate>Fri, 14 Jan 2011 00:19:00 +0000</pubDate> 
				<category><![CDATA[Cardiology]]></category>
		<category><![CDATA[Cardiology: Non-Interventional]]></category>
		<category><![CDATA[Hospitalist]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Nurses/NP/PA]]></category>
		<category><![CDATA[Pharmacists]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[amiodarone]]></category>
		<category><![CDATA[Dr. A. John Camm]]></category>
		<category><![CDATA[ecent-onset atrial fibrillation]]></category>
		<category><![CDATA[Journal of the American College of Cardiology]]></category>
		<category><![CDATA[vernakalant]]></category>
		<guid isPermaLink="false">http://new.thedoctorschannel.com/view/vernakalant-bests-amiodarone-for-recent-onset-atrial-fibrillation-2/</guid>
		<description><![CDATA[NEW YORK (Reuters Health) &#8211; For conversion of recent-onset atrial fibrillation, vernakalant acted more rapidly and was more effective than amiodarone in an international study. As reported in the Journal of the American College of Cardiology online January 10th, more than 50% of vernakalant patients in the phase III trial achieved sinus rhythm within the -]]></description>
		
			<media:content duration="1:34" medium="video">
		<media:title><![CDATA[Vernakalant bests amiodarone for recent-onset atrial fibrillation]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) &#8211; For conversion of recent-onset atrial fibrillation, vernakalant acted more rapidly and was more effective than amiodarone in an international study. As reported in the Journal of the American College of Cardiology online January 10th, more than 50% of vernakalant patients in the phase III trial achieved sinus rhythm within the -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/vernakalant-bests-amiodarone-for-recent-onset-atrial-fibrillation-2/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2011/06/4011.jpg"/>
	<media:keywords><![CDATA[amiodarone,Dr. A. John Camm,ecent-onset atrial fibrillation,Journal of the American College of Cardiology,vernakalant]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Heart failure patients benefit from n-3 PUFAs</title>
		<link>http://www.thedoctorschannel.com/view/heart-failure-patients-benefit-from-n-3-pufas-2/</link>
		<pubDate>Sat, 08 Jan 2011 02:38:00 +0000</pubDate> 
				<category><![CDATA[Cardiology]]></category>
		<category><![CDATA[Cardiology: Non-Interventional]]></category>
		<category><![CDATA[Family Medicine]]></category>
		<category><![CDATA[Hospitalist]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Medical Students]]></category>
		<category><![CDATA[Nurses/NP/PA]]></category>
		<category><![CDATA[Pharmacists]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[chronic stable heart failure]]></category>
		<category><![CDATA[Dr. Mihai Gheorghiade]]></category>
		<category><![CDATA[functional capacity]]></category>
		<category><![CDATA[HF]]></category>
		<category><![CDATA[Journal of the American College of Cardiology]]></category>
		<category><![CDATA[left ventricular ejection fraction]]></category>
		<category><![CDATA[n-3 polyunsaturated fatty acids]]></category>
		<category><![CDATA[n-3 PUFAs]]></category>
		<guid isPermaLink="false">http://new.thedoctorschannel.com/view/heart-failure-patients-benefit-from-n-3-pufas-2/</guid>
		<description><![CDATA[NEW YORK (Reuters Health) &#8211; In patients with chronic stable heart failure (HF) due to nonischemic dilated cardiomyopathy, a year’s treatment with n-3 polyunsaturated fatty acids (n-3 PUFAs) increases left ventricular ejection fraction and functional capacity, new research shows. Although these are surrogate markers, the authors suggest that these effects “may favorably affect cardiac remodeling -]]></description>
		
			<media:content duration="1:56" medium="video">
		<media:title><![CDATA[Heart failure patients benefit from n-3 PUFAs]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) &#8211; In patients with chronic stable heart failure (HF) due to nonischemic dilated cardiomyopathy, a year’s treatment with n-3 polyunsaturated fatty acids (n-3 PUFAs) increases left ventricular ejection fraction and functional capacity, new research shows. Although these are surrogate markers, the authors suggest that these effects “may favorably affect cardiac remodeling -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/heart-failure-patients-benefit-from-n-3-pufas-2/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2011/06/4000.jpg"/>
	<media:keywords><![CDATA[chronic stable heart failure,Dr. Mihai Gheorghiade,functional capacity,HF,Journal of the American College of Cardiology,left ventricular ejection fraction,n-3 polyunsaturated fatty acids,n-3 PUFAs]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Type of statins given to HIV-infected people should be reconsidered: study</title>
		<link>http://www.thedoctorschannel.com/view/type-of-statins-given-to-hiv-infected-people-should-be-reconsidered-study-2/</link>
		<pubDate>Thu, 06 Jan 2011 02:36:00 +0000</pubDate> 
				<category><![CDATA[Cardiology]]></category>
		<category><![CDATA[Cardiology: Non-Interventional]]></category>
		<category><![CDATA[HIV/AIDS]]></category>
		<category><![CDATA[Hospitalist]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Nurses/NP/PA]]></category>
		<category><![CDATA[Pharmacists]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[Clinical Infectious Diseases]]></category>
		<category><![CDATA[Dr. Heidi Crane]]></category>
		<category><![CDATA[dyslipidemia]]></category>
		<category><![CDATA[HIV]]></category>
		<category><![CDATA[rosuvastatin]]></category>
		<guid isPermaLink="false">http://new.thedoctorschannel.com/view/type-of-statins-given-to-hiv-infected-people-should-be-reconsidered-study-2/</guid>
		<description><![CDATA[Rosuvastatin should be considered for HIV-positive people with dyslipidemia — and guidelines should be updated to reflect that, suggests a new study. Although guidelines from the Infectious Diseases Society of America and the Adult AIDS Clinical Trials Group recommend pravastatin or atorvastatin for these individuals, authors of the current study, published in Clinical Infectious Diseases, -]]></description>
		
			<media:content duration="1:26" medium="video">
		<media:title><![CDATA[Type of statins given to HIV-infected people should be reconsidered: study]]></media:title>
	<media:description><![CDATA[Rosuvastatin should be considered for HIV-positive people with dyslipidemia — and guidelines should be updated to reflect that, suggests a new study. Although guidelines from the Infectious Diseases Society of America and the Adult AIDS Clinical Trials Group recommend pravastatin or atorvastatin for these individuals, authors of the current study, published in Clinical Infectious Diseases, -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/type-of-statins-given-to-hiv-infected-people-should-be-reconsidered-study-2/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2011/06/3994.jpg"/>
	<media:keywords><![CDATA[Clinical Infectious Diseases,Dr. Heidi Crane,dyslipidemia,HIV,rosuvastatin]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>New data prompt “focused” update of atrial fibrillation guidelines</title>
		<link>http://www.thedoctorschannel.com/view/new-data-prompt-focused-update-of-atrial-fibrillation-guidelines/</link>
		<pubDate>Thu, 06 Jan 2011 02:19:00 +0000</pubDate> 
				<category><![CDATA[Cardiology]]></category>
		<category><![CDATA[Cardiology: Interventional]]></category>
		<category><![CDATA[Cardiology: Non-Interventional]]></category>
		<category><![CDATA[Hospitalist]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Medical Students]]></category>
		<category><![CDATA[Nurses/NP/PA]]></category>
		<category><![CDATA[Pharmacists]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[atrial fibrillation]]></category>
		<category><![CDATA[circulation]]></category>
		<category><![CDATA[Dr. L. Samuel Wann]]></category>
		<category><![CDATA[dronedarone]]></category>
		<category><![CDATA[HeartRhythm]]></category>
		<category><![CDATA[Journal of the American College of Cardiology]]></category>
		<category><![CDATA[lenient control]]></category>
		<category><![CDATA[strict heart rate control]]></category>
		<category><![CDATA[warfarin]]></category>
		<guid isPermaLink="false">http://new.thedoctorschannel.com/view/new-data-prompt-focused-update-of-atrial-fibrillation-guidelines/</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – In patients with atrial fibrillation, strict heart rate control provides no advantage over more lenient control, according to a focused update of the 2006 guidelines for the management of patients with atrial fibrillation. The heart rate recommendation, one of several in the update, states that strict treatment to keep a -]]></description>
		
			<media:content duration="1:24" medium="video">
		<media:title><![CDATA[New data prompt “focused” update of atrial fibrillation guidelines]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – In patients with atrial fibrillation, strict heart rate control provides no advantage over more lenient control, according to a focused update of the 2006 guidelines for the management of patients with atrial fibrillation. The heart rate recommendation, one of several in the update, states that strict treatment to keep a -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/new-data-prompt-focused-update-of-atrial-fibrillation-guidelines/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2011/06/3993.jpg"/>
	<media:keywords><![CDATA[atrial fibrillation,circulation,Dr. L. Samuel Wann,dronedarone,HeartRhythm,Journal of the American College of Cardiology,lenient control,strict heart rate control,warfarin]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Spironolactone improves heart failure survival</title>
		<link>http://www.thedoctorschannel.com/view/spironolactone-improves-heart-failure-survival-2/</link>
		<pubDate>Fri, 31 Dec 2010 00:44:00 +0000</pubDate> 
				<category><![CDATA[Cardiology]]></category>
		<category><![CDATA[Cardiology: Non-Interventional]]></category>
		<category><![CDATA[Family Medicine]]></category>
		<category><![CDATA[Hospitalist]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Medical Students]]></category>
		<category><![CDATA[Nurses/NP/PA]]></category>
		<category><![CDATA[Pharmacists]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[American Heart Journal]]></category>
		<category><![CDATA[Dr. Hiroyuki Tsutsui]]></category>
		<category><![CDATA[Spironolactone]]></category>
		<category><![CDATA[systolic heart failure]]></category>
		<guid isPermaLink="false">http://new.thedoctorschannel.com/view/spironolactone-improves-heart-failure-survival-2/</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – Spironolactone use is associated with improved long-term survival in patients with systolic heart failure, researchers from Japan report in the December American Heart Journal. “Widespread application of spironolactone use in clinical practice may substantially improve the outcomes in the large numbers of patients hospitalized with heart failure,” Dr. Hiroyuki Tsutsui -]]></description>
		
			<media:content duration="1:36" medium="video">
		<media:title><![CDATA[Spironolactone improves heart failure survival]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – Spironolactone use is associated with improved long-term survival in patients with systolic heart failure, researchers from Japan report in the December American Heart Journal. “Widespread application of spironolactone use in clinical practice may substantially improve the outcomes in the large numbers of patients hospitalized with heart failure,” Dr. Hiroyuki Tsutsui -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/spironolactone-improves-heart-failure-survival-2/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2011/06/3984.jpg"/>
	<media:keywords><![CDATA[American Heart Journal,Dr. Hiroyuki Tsutsui,Spironolactone,systolic heart failure]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
	</channel>
</rss>
